Challa, T.R. et al. 2026. A 3% topical gel formulation of tenofovir disoproxil fumarate (TDF) for the treatment of human immunodeficiency virus (HIV) by experimental approach. Current Issues in Pharmacy and Medical Sciences. 39, 1 (Mar. 2026), 7–13. DOI:https://doi.org/10.12923/cipms-2026-0002.